Get the Stockscreener App
476.16
1.34%
6.28
Intuitive Surgical Inc stock is traded at $476.16, with a volume of 1.74M.
It is up +1.34% in the last 24 hours and down -6.82% over the past month.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$469.88
Open:
$473
24h Volume:
1.74M
Relative Volume:
1.00
Market Cap:
$170.69B
Revenue:
$9.15B
Net Income/Loss:
$2.63B
P/E Ratio:
66.41
EPS:
7.17
Net Cash Flow:
$1.99B
1W Performance:
-0.85%
1M Performance:
-6.82%
6M Performance:
-19.54%
1Y Performance:
-2.91%
1-Day Range:
$469.85
$478.97
1-Week Range:
$461.25
$487.20
52-Week Range:
$425.00
$616.00
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
476.16 | 172.53B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
199.66 | 55.89B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
82.02 | 43.59B | 9.93B | 1.12B | 1.43B | 2.26 |
|
RMD
Resmed Inc
|
293.73 | 41.89B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
247.85 | 17.48B | 2.96B | 487.70M | 344.00M | 6.68 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-25 | Downgrade | Erste Group | Buy → Hold |
| Jun-09-25 | Downgrade | Deutsche Bank | Hold → Sell |
| Jun-05-25 | Upgrade | Erste Group | Hold → Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Nov-17-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-19-23 | Reiterated | BTIG Research | Buy |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Evercore ISI | In-line |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-19-23 | Reiterated | Raymond James | Outperform |
| Apr-19-23 | Reiterated | Stifel | Buy |
| Apr-19-23 | Reiterated | Truist | Buy |
| Apr-19-23 | Reiterated | Wells Fargo | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-23-23 | Initiated | William Blair | Outperform |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-13-22 | Initiated | Mizuho | Neutral |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
| Jan-21-22 | Reiterated | BTIG Research | Buy |
| Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Evercore ISI | In-line |
| Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-21-22 | Reiterated | Piper Sandler | Neutral |
| Jan-21-22 | Reiterated | Raymond James | Outperform |
| Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Reiterated | UBS | Neutral |
| Jan-21-22 | Reiterated | Wells Fargo | Overweight |
| Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Jul-21-21 | Reiterated | BofA Securities | Neutral |
| Jul-21-21 | Reiterated | Citigroup | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Jul-21-21 | Reiterated | Piper Sandler | Neutral |
| Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jul-21-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Reiterated | Wells Fargo | Overweight |
| Jul-14-21 | Reiterated | Goldman | Buy |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-28-20 | Initiated | Argus | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jul-20-20 | Reiterated | Bernstein | Outperform |
| Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-17-20 | Downgrade | CFRA | Hold → Sell |
| Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-19 | Reiterated | Wells Fargo | Outperform |
| Nov-21-19 | Initiated | Oppenheimer | Perform |
| Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-02-19 | Initiated | Deutsche Bank | Buy |
| Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
| Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
Evercore ISI Lowered the Firm’s PT on Intuitive Surgical (ISRG), Kept an In Line Rating - MSN
Intuitive Surgical GM Iman Jeddi to share at RoboBusiness how the company keeps innovating - The Robot Report
Stock Analysis | Intuitive Surgical OutlookMixed Signals Cloud Short-Term Prospects Amid Strong Fundamentals - AInvest
Jim Cramer on Intuitive Surgical: “I Like That Company So Much” - MSN
Intuitive Surgical's Stock Slides as 93rd-Busiest Trade Amid Asia Expansion Hurdles - AInvest
ISRG's International Push for Ion: Strategic Bet or Overstretch? - The Globe and Mail
Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know - Yahoo Finance
CMR Surgical hires Chris O’Hara to drive US robot expansion - Yahoo Finance
Intuitive Surgical's Robotic Surge: Can Long-Term Growth Offset Near-Term Pressures? - AInvest
Neurosurgery Surgical Robots Market Generated Opportunities, - openPR.com
If You're in Your 30s, Consider Buying These 2 Healthcare Stocks - AOL.com
If You're in Your 30s, Consider Buying These 2 Healthcare Stocks - The Motley Fool
Bernstein Raises PT on Intuitive Surgical, Inc. (ISRG) to $685; Maintains ‘Outperform’ Rating - Yahoo Finance
Baird Raises PT on Intuitive Surgical (ISRG) to $600 From $590, Keeps an Overweight Rating - msn.com
Intuitive Surgical Q2 2025 slides: 21% revenue growth fueled by da Vinci 5 adoption - Investing.com Nigeria
Intuitive Surgical Slides 1.09% on 97th-Ranked $900M Volume Amid Bearish Signals and Cautious Rally Outlook - AInvest
Intuitive Surgical Inc. Hits Oversold Level on RSI IndicatorInflation Watch & AI Powered Market Entry Strategies - beatles.ru
Surgical Robot Procedures Market | Industry Report, 2033 - Grand View Research
Intuitive Surgical Inc. Breakout Confirmed by Volume MetricsDividend Hike & Daily Growth Stock Tips - metal.it
ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue? - sharewise.com
Intuitive Surgical's $170 Billion Value Holds Room for Growth Despite Underperformance. - AInvest
Intuitive Surgical Has More Room To Grow (NASDAQ:ISRG) - Seeking Alpha
ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story - Nasdaq
Comparison of Surgical Outcomes Between the hinotori™ and da Vinci® Robotic Systems in Robot-Assisted Sacrocolpopexy: A Retrospective Study - Cureus
Surgical Robotics Simulation Market Industry Developments and Strategic Collaborations Accelerate Growth Trajectory - openPR.com
Intuitive Surgical’s ISRG Climbs 0.38% on $670M Volume, Ranked 142nd as Robotic Surgery Market Expands - AInvest
Global Clinical Robotic Systems Market Is Booming So Rapidly By 2032 | Intuitive Surgical Inc., Stryker Corporation - openPR.com
Here's Why We Think Intuitive Surgical (NASDAQ:ISRG) Might Deserve Your Attention Today - 富途牛牛
AI-based Surgical Robots Market Exclusive Report with Detailed - openPR.com
Apreo raises $130M for pivotal trial of emphysema device - MedTech Dive
Bay Area company breathes new life into fight against emphysema - The Business Journals
2 Surefire Stocks to Invest $1,000 in for the Long Haul - The Globe and Mail
Jim Cramer Praises Intuitive Surgical: "I Like That Company So Much" - AInvest
Jim Cramer on Intuitive Surgical: "I Like That Company So Much" - Yahoo Finance
FTC Maintains Support For Right-To-Repair In Med Robot Case - Law360
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock - MSN
Orthopedic Medical Robots Market Gains Momentum & Attracts - openPR.com
Intuitive Surgical Shares Dip 0.9% as Volume Plummets 20% to Rank 126th Despite Analyst Upgrades - AInvest
Intuitive Surgical, Inc. shares fall 1.82% intraday as Nasdaq gains led by Apple. - AInvest
Leerink Partners Raises PT on Intuitive Surgical, Maintains Buy Rating - AInvest
Leerink Partners Raised the Firm’s PT on Intuitive Surgical (ISRG), Kept a Buy Rating - Insider Monkey
Q2 Earnings Highs And Lows: Intuitive Surgical (NASDAQ:ISRG) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - ca.finance.yahoo.com
Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots - AOL.com
11 Best Stocks to Invest in for High Returns - Insider Monkey
Radiology Oncology Surgical Robots Market Generated - openPR.com
Fund Update: TRILLIUM ASSET MANAGEMENT, LLC added 23,043 shares of INTUITIVE SURGICAL ($ISRG) to their portfolio - Quiver Quantitative
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Intuitive Surgical Inc Stock (ISRG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GUTHART GARY S | Executive Chair of the Board o |
Jul 28 '25 |
Sale |
498.64 |
7,893 |
3,935,756 |
13,187 |
| GUTHART GARY S | Executive Chair of the Board o |
Jul 28 '25 |
Sale |
495.24 |
2,800 |
1,386,663 |
18,520 |
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):